
Homeoffice Director, Regional Marketing & Customer Engagement
Kuraoncology · Boston, San Diego, Remote, États-Unis d'Amérique · Remote
Les clés des livres en 15 minutes. Économisez 40% dès maintenant!
Sponsorisé par Blinkist
Apprends en ligne les compétences des meilleures universités. Faites avancer votre carrière dès aujourd'hui!
Sponsorisé par Coursera
Deviens un designer en suivant des cours pratiques et en bénéficiant d'un mentorat.
Sponsorisé par Designlab
Kuraoncology · Boston, San Diego, Remote, États-Unis d'Amérique · Remote
Kuraoncology · Boston, San Diego, Remote, États-Unis d'Amérique · Remote
Postuler maintenant
Exponent – Réussis tes entretiens tech avec des simulations et des coachs experts issus des meilleures entreprises.
Sponsorisé par ExponentAre you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
Director of Regional Marketing & Key Customer Engagements
We are seeking a Director of Regional Marketing & Key Customer Engagements who will shape the strategy, planning, and execution for the Associate Directors of Regional Marketing, while also acting as a Regional Marketing Lead for a given Region. This role involves overseeing the strategic engagement with Hematologist-Oncologist Thought Leaders at both National and Regional levels. The Director of Regional Marketing & Key Customer Engagements will provide leadership of the development, planning and execution of Thought Leader engagement strategy, plans and execution, ensuring alignment with the organization’s corporate strategy, brand positioning, and lifecycle management to ensure brand success and optimization ongoing.
Essential Job Functions
JOB SPECIFICATIONS:
The base range for a Director is $211,000 - $255,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
Kura’s Values that are used for candidate selection and performance assessments:
The Kura Package
Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.
Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.